HIGHLIGHTS
- who: Leslie Cuellar-Vite and collaborators from the Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA have published the Article: Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy, in the Journal: Cancers 2022, x of /2022/
- what: As an alternative approach to discovering mechanisms of resistance to mTORC1i, the authors focused on a breast cancer subtype (TNBC) where intrinsic in_vitro resistance is well-established. Immunological response is unlikely to play a role in the synergy between FAK and mTORC1i because the studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.